X0609 4 2026-10-06 true 0000834365 BIOLIFE SOLUTIONS INC BLFS 0001669207 MOORE TIMOTHY L. false 3303 MONTE VILLA PARKWAY SUITE 310 BOTHELL WA 98021 true false false false false Common Stock 2026-10-06 4 D false 44943 D 0 D Reflects the disposition of shares of common stock ("Common Stock") of BioLife Solutions, Inc. (the "Registrant") in connection with the consummation on October 6, 2026 of the merger of Bravo Merger Sub I, Inc., a Delaware corporation ("Merger Sub 1") with and into the Registrant (the "First Merger"), pursuant to the Agreement and Plan of Merger, dated as of July 21, 2026 (the "Merger Agreement"), by and among the Registrant, Repligen Corporation, a Delaware corporation ("Repligen"), Merger Sub 1 and Bravo Merger Sub II, LLC, a Delaware limited liability company. At the effective time of the First Merger (the "First Merger Effective Time"), each outstanding share of Common Stock was converted into the right to receive $11.25 in cash and 0.1442 shares of Repligen common stock, in each case subject to the terms and conditions of the Merger Agreement. /s/ Timothy L. Moore 2026-10-08